» Authors » Jodi Segal

Jodi Segal

Explore the profile of Jodi Segal including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 38
Citations 909
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
11.
Benkeser D, Diaz I, Luedtke A, Segal J, Scharfstein D, Rosenblum M
Biometrics . 2020 Sep; 77(4):1467-1481. PMID: 32978962
Time is of the essence in evaluating potential drugs and biologics for the treatment and prevention of COVID-19. There are currently 876 randomized clinical trials (phase 2 and 3) of...
12.
Benkeser D, Diaz I, Luedtke A, Segal J, Scharfstein D, Rosenblum M
medRxiv . 2020 Jun; PMID: 32577668
Time is of the essence in evaluating potential drugs and biologics for the treatment and prevention of COVID-19. There are currently over 400 clinical trials (phase 2 and 3) of...
13.
Green A, Segal J, Boyd C, Huang J, Roth D
Drugs Real World Outcomes . 2020 Feb; 7(2):151-159. PMID: 32052322
Background: Emergency department (ED) visits or hospitalizations should prompt review of the patient's medications after discharge and targeted deprescribing to reduce ongoing risks. Objective: To see if this is happening,...
14.
Nicholas L, Segal J, Hanson C, Zhang K, Eisenberg M
Health Aff (Millwood) . 2019 May; 38(5):788-793. PMID: 31059371
In the period 2012-15, 1,364 fraud and abuse perpetrators (FAPs) treated over 1.2 million Medicare beneficiaries and received more than $630 million in Medicare payments. Compared to beneficiaries treated by...
15.
Lanzkron S, Little J, Field J, Shows J, Wang H, Seufert R, et al.
Blood Adv . 2018 Sep; 2(18):2412-2417. PMID: 30254105
The ESCAPED (Examining Sickle Cell Acute Pain in the Emergency vs Day Hospital) trial is an ongoing prospective study comparing outcomes of people with sickle cell disease (SCD) seeking care...
16.
17.
Green A, Segal J, Tian J, Oh E, Roth D, Hilson L, et al.
J Am Geriatr Soc . 2017 Feb; 65(2):390-394. PMID: 28185237
Objective: To examine the use of antimuscarinics for treating urinary incontinence (UI) in older adults with varying levels of cognition. Design: Cross-sectional. Setting: National Alzheimer's Coordinating Center from 2005 through...
18.
19.
Pathak R, Schroeder E, Seaquist E, Zeng C, Lafata J, Thomas A, et al.
Diabetes Care . 2015 Dec; 39(3):363-70. PMID: 26681726
Objective: Appropriate glycemic control is fundamental to diabetes care, but aggressive glucose targets and intensive therapy may unintentionally increase episodes of hypoglycemia. We quantified the burden of severe hypoglycemia requiring...
20.
Vazquez-Benitez G, Desai J, Xu S, Goodrich G, Schroeder E, Nichols G, et al.
Diabetes Care . 2015 Feb; 38(5):905-12. PMID: 25710922
Objective: The objective of this study was to assess the incidence of major cardiovascular (CV) hospitalization events and all-cause deaths among adults with diabetes with or without CV disease (CVD)...